Stage IIC Fallopian Tube Cancer AJCC v6 and v7

specific

Stage II includes: (T2, N0, M0); IIA: (T2a, N0, M0); IIB (T2b, N0, M0); IIC (T2c, N0, M0). T2: Tumor involves one or both fallopian tubes with pelvic extension. T2a: Extension and/or metastasis to the uterus and/or ovaries. T2b: Extension to other pelvic structures. T2c: Pelvic extension with malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)

69

Centers

87

Active Trials

Cancer Funding

Top Centers for Stage IIC Fallopian Tube Cancer AJCC v6 and v7(69)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
65.1
2
NCI Comprehensive
Active Research Program
65.1
3
NCI Comprehensive
Active Research Program
65.1
4
NCI Comprehensive
Active Research Program
65.1
5
NCI Comprehensive
Active Research Program
65.1
665.1
7
NCI Comprehensive
Active Research Program
65.1
8
NCI Comprehensive
Active Research Program
65.1
9
NCI Comprehensive
Active Research Program
65.1
10
NCI Comprehensive
Active Research Program
65.1
11
NCI Comprehensive
Active Research Program
65.1
12
Active Research Program
65.1
13
Active Research Program
65.1
14
NCI Clinical
Active Research Program
65.1
15
Active Research Program
65.1
16
NCI Clinical
Active Research Program
65.1
17
NCI Comprehensive
Active Research Program
65.1
18
Active Research Program
65.1
1965.1
20
Active Research Program
65.1
21
Active Research Program
65.1
22
Active Research Program
65.1
23
Active Research Program
65.1
24
Active Research Program
65.1
25
Active Research Program
65.1
26
NCI Comprehensive
Active Research Program
44.9
27
NCI Comprehensive
Active Research Program
44.9
28
NCI Comprehensive
Active Research Program
44.9
29
NCI Comprehensive
Active Research Program
44.9
30
NCI Comprehensive
Active Research Program
44.9
31
NCI Comprehensive
Active Research Program
44.9
32
NCI Comprehensive
Active Research Program
44.9
33
NCI Comprehensive
Active Research Program
44.9
34
NCI Comprehensive
Active Research Program
44.9
35
NCI Comprehensive
Active Research Program
44.9
36
NCI Comprehensive
Active Research Program
44.9
37
NCI Comprehensive
Active Research Program
44.9
38
NCI Comprehensive
Active Research Program
44.9
39
NCI Comprehensive
Active Research Program
44.9
40
NCI Comprehensive
Active Research Program
44.9
41
NCI Comprehensive
Active Research Program
44.9
42
NCI Clinical
Active Research Program
44.9
43
NCI Comprehensive
Active Research Program
44.9
44
NCI Comprehensive
Active Research Program
44.9
45
NCI Comprehensive
Active Research Program
44.9
46
NCI Clinical
Active Research Program
44.9
47
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
44.9
48
NCI Comprehensive
Active Research Program
44.9
49
Active Research Program
44.9
50
NCI Comprehensive
Active Research Program
44.9
51
NCI Comprehensive
Active Research Program
44.9
52
NCI Comprehensive
Active Research Program
44.9
53
NCI Comprehensive
Active Research Program
44.9
54
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
44.9
55
Active Research Program
44.9
56
NCI Comprehensive
Active Research Program
44.9
57
Active Research Program
44.9
58
Active Research Program
44.9
59
Active Research Program
44.9
60
Active Research Program
44.9
61
Active Research Program
44.9
62
Active Research Program
44.9
63
NCI Comprehensive
30.5
64
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
30.5
65
NCI Comprehensive
30.5
66
NCI Comprehensive
30.5
67
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
30.5
68
NCI Basic_laboratory
30.5
6930.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →